Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone vs High Dose Interferon in Relapsing MS
NCT00202995Phase 4Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2004
- Primary completion
- Oct 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2004; status: terminated.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00202995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202995.